Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma

BACKGROUND: High-grade meningiomas are aggressive tumors with high morbidity and mortality rates that frequently recur even after surgery and adjuvant radiotherapy. However, limited information is currently available on the biology of these tumors, and no alternative adjuvant treatment options exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Masahiro, Sanomachi, Tomomi, Suzuki, Shuhei, Uchida, Hiroyuki, Yonezawa, Hajime, Higa, Nayuta, Takajo, Tomoko, Yamada, Yuki, Sugai, Asuka, Togashi, Keita, Seino, Shizuka, Okada, Masashi, Sonoda, Yukihiko, Hirano, Hirofumi, Yoshimoto, Koji, Kitanaka, Chifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168817/
https://www.ncbi.nlm.nih.gov/pubmed/33556172
http://dx.doi.org/10.1093/neuonc/noab015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168817/
https://www.ncbi.nlm.nih.gov/pubmed/33556172
http://dx.doi.org/10.1093/neuonc/noab015

Ejemplares similares